Pharmacotherapy in Psychiatry and Neurology
eISSN: 2449-9315
ISSN: 1234-8279
Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Ethical standards and procedures Reviewers Instructions for authors
Editorial System
Submit your Manuscript
2/2025
vol. 41
 
Share:
Share:
abstract:
Case report

Potentiation of antidepressant treatment with racemic ketamine in a patient with an episode of severe depression in the course of bipolar disorder (BD) and a positive history of psychotic mania – a case report

Gracja Ryznar
1
,
Katarzyna M. Bliźniewska-Kowalska
1
,
Piotr Gałecki
1

  1. Department of Adult Psychiatry, Medical University of Lodz, Poland; Klinika Psychiatrii Dorosłych Uniwersytetu Medycznego w Łodzi, Łodź, Polska
Farmakoterapia w Psychiatrii i Neurologii 2025
Online publish date: 2026/04/28
View full text Get citation
 
PlumX metrics:
Objectives
Although ketamine has become standard treatment for unipolar depression, particularly drug-resistant depression, its use for bipolar depression requires careful consideration of potential benefits and risks, especially in patients with a history of psychotic symptoms.

Case report
In a 52-year-old man with BD, the depressive episode was severe and showed no satisfactory improvement despite multiple changes to pharmacotherapy; therefore, augmentation with intravenous racemic ketamine was considered. However, concern was raised because the patient had experienced a severe manic episode with psychotic features seven years earlier. The patient received racemic ketamine.

Conclusions
A prior history of manic episodes or psychotic symptoms in BD should not automatically preclude ketamine treatment; however, a detailed, individualised risk assessment is essential in each case.

keywords:

bipolar disorder, depression, psychotic symptoms, ketamine


Quick links
© 2026 Termedia Sp. z o.o.
Developed by Termedia.